The International Waldenstrom’s Macroglobulinemia Foundation (IWMF)
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a patient-founded and patient-led non-profit organization, comprised of 99% volunteers and represents 32,000 Waldenstrom’s patients worldwide! They want you to know with the IWMF, you are never alone and anyone can become a member. As the IWMF strives to support the lives of those living with this rare cancer, the organization offers critical services to achieve that end.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Resources & Support
Patient Worthy Posts on Waldenstrom Macroglobulinemia
Second-Ever Therapy for Waldenström’s Macroglobulinemia is Now FDA Approved
The FDA has just announced their approval of zanubrutinib (Brukinsa) as a therapeutic option for Waldenström’s macroglobulinemia. This approval was given based on the ASPEN
ICYMI: Country Singer Ashley Monroe Diagnosed with WM
Ashley Monroe is an extremely talented singer-songwriter who hails from Tennessee. Over the years, Ashley has grown her music career alone and as part of
IWMF Webinar: ASCO 2021 Advances in WM
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) recently held the latest webinar in its Global Education series on July 9, 2021. This webinar was a summary
IWMF Webinar Covers WM Peripheral Neuropathy
On May 4th The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) held another webinar in its 2021 IWMF Global Education series titled Peripheral Neuropathy: No Easy Feat.
WM: The Latest Treatment Approaches
Recently the Leukemia & Lymphoma Society (LLS), in coordination with the International Waldenstrom’s Macroglobulinemia Foundation (IWMF), hosted its Waldenström’s Macrogloblinemia (WM) Patient Education Program webinar
IWMF Webinar Presents Vital Info on Clinical Trials
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) recently hosted a webinar presentation on February 9, 2021. This webinar, titled “Why Clinical Trials Matter and How to
